Se-cure is a research-driven Israeli Pharmaceutical company, which has developed a proprietary platform for the discovery, development and scaling of therapies from botanical origin. Founded in 1997, Se-cure processes natural complex of biochemical compounds as found in the original plant, as a basis for designing therapies which selectively target specific tissues, while leaving other tissues intact. Se-cure’s competencies include target manipulated germination and proprietary agro-technologies used to engineer botanicals into tissue targeted therapeutics. Se-cure owns and operates an advanced pharmaceutical manufacturing facility operating under rigorous standards of pharmaceutical cGMPs, ISO 9001:2008, BVQI, the environmental quality control of ISO 14001:2004, and additional local quality control standards (TGA approved).